Try our Advanced Search for more refined results

October 27, 2016

Galderma Laboratories, L.P. et al v. Sun Pharmaceutical Industries Limited et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. October 08, 2019

    Sun Pharma Biosimilar Infringes Galderma Oracea Patents

    After wrestling with a late request to reconstrue a key term in the case, a Delaware federal judge has determined that Sun Pharmaceutical Industry Limited's biosimilar of Galderma's flagship drug Oracea used to treat the skin condition rosacea infringes three Galderma patents covering the drug.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!